Supporting Community Development Initiatives (SCDI)

Email

oanhkhuat@scdi.org.vn

Phone

T: +84 8357 20679

Web

www.scdi.org.vn

Address

240 Mai Anh Tuan, Thanh Cong, Ba Dinh Hanoi 1000 Vietnam
About Supporting Community Development Initiatives (SCDI)

Established in January 2010, the Center for Supporting Community Development Initiatives (SCDI) is a non-governmental, non-profit organization registered under the Vietnam Union of Science and Technology Associations.

Philosophy and Approach
SCDI deeply believes that each individual and community has great hidden potential, which can be used not only to tackle their own problems, but also to contribute to the development of the society. Through the approach of empowerment together with policy advocacy, SCDI aims to create motivation and an environment for these potentials to be realized in favor of positive goals.

Mission
SCDI aims to enhance the quality of life and the ability of vulnerable and disadvantaged populations to integrate into society through researching, designing, experimenting, implementing, and promoting community development models.

Purposes
Implement research and support research on sustainable development, design comprehensive and sustainable development models with the engagement of the community.

Experiment, reproduce and promote models that engage and encourage the potential of different populations in the community… into the development of the country.

Carry out scientific and technological services: counseling, training, information disseminating in order to apply research result to reality.
Cooperate with organizations and individuals inside and outside of the country to implement activities related to sustainable development.

Goals
Improve the quality of life of marginalized and vulnerable populations.

Strategic objectives
Support the organizational development of the target populations in terms of both quality and quality, with the aim to help these groups to build the capacity to be able to propose and implement initiatives that benefit their own communities.

Advocate for policies to eliminate the barriers to the establishment and development of community groups and/or opportunities that enhance the quality of life for the community, including barriers in policy, awareness, social issues and resources.

Design, experiment, implement, disseminate, promote, and replicate models and initiatives that aim to enhance the quality of life of target populations.

Maintain and improve SCDI to be a strong NGO with the capacity to attract resources to fulfill its mission.

Sign up to receive updates from WHA

Name(Required)
I would like to hear about(Required)

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Hepatitis and PWID/harm reduction 

 

11:35 – 11:40  

Chair: WHO – Intro and set the scene.  

 

11:40 – 11:55  

Co-chair:  EMCDDA – Monitoring viral hepatitis elimination among PWID in Europe. 

 

11:55 – 12:00 

ID 29: Ema Pos (not yet registered) 

Title: If the mountain won’t come to Mohammed: lessons from a decentralized Infectious Disease consultation. 

 

12:05 – 12:10  

ID 152: Brian Conway (Registered in person) 

Title: Community Pop-up Clinic: Cascade of Care and HCV Treatment of Vancouver’s inner-city PWID Populations.

 

12:10 – 12:15 

ID 212: Jasmine West (not yet registered) 

Title: From lived experience to lived expertise: a syndemic approach. 

 

12:15 – 12:20 

ID: 299 Mercy Nyakowa (Registered in person) 

Title: HCV and HBV prevalence and associated risk factors among people who inject drugs (PWIDs) in Kenya 

 

12:20 – 12:25 

ID: 133 Nalinikanta Rajkumar (Registered in person) 

Title: Rapid regimen of HBV vaccination: Does it work for high risk groups?  

 

12:25 – 12:30 

Q&A and closing remarks   

tHIS

 

IS 

 

BEN’S

 

 

 

BIG 

 

 

TEST

effective case finding strategies

Supported by Vir Biotechnology, Inc

During this session you will hear from hepatitis Delta expert, Dr. Maria Buti, and a patient who has lived with hepatitis Delta in a panel discussion moderated by Dr. Carey Hwang, Chief Medical Officer (interim) of Vir Biotechnology. This panel will inform perspectives on patient needs, opportunities for enhanced screening, and strengthening linkages to care.

Session Agenda

14:40 – 14:45    

Panel overview and introductions facilitated by Dr Carey Hwang (Vir Biotechnology)

14:45 – 15:05   

Panel discussion: Dr Maria Buti (University Hospital Vall d’Hebron, Spain), Milanka Barbosa, Dr Carey Hwang (Chief Medical Officer interim), Vir Biotechnology

15:05 – 15:10    

Final remarks and close